Biocorrx Inc New (BICX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -860 | -3,509 | -3,038 | -2,229 | -852 |
| Depreciation Amortization | 137 | 617 | 608 | 403 | 201 |
| Accounts receivable | -77 | -254 | -216 | -51 | -112 |
| Other Working Capital | 60 | -515 | 465 | 523 | -339 |
| Other Operating Activity | 307 | 1,361 | 730 | 538 | 412 |
| Operating Cash Flow | $-433 | $-2,298 | $-1,451 | $-816 | $-690 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11 | 1,148 | 942 | 848 | 633 |
| Debt Repayment | -5 | -677 | -7 | -7 | -7 |
| Common Stock Issued | 500 | 1,879 | 716 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -1 | 0 |
| Financing Cash Flow | $506 | $2,350 | $1,650 | $840 | $626 |
| Beginning Cash Position | 139 | 88 | 88 | 88 | 88 |
| End Cash Position | 212 | 139 | 288 | 112 | 24 |
| Net Cash Flow | $73 | $51 | $200 | $24 | $-64 |
| Free Cash Flow | |||||
| Operating Cash Flow | -433 | -2,298 | -1,451 | -816 | -690 |
| Free Cash Flow | -433 | -2,298 | -1,451 | -816 | -690 |